Organon & Co.·4

Mar 31, 4:05 PM ET

Morrissey Joseph T. Jr. 4

4 · Organon & Co. · Filed Mar 31, 2026

Research Summary

AI-generated summary of this filing

Updated

Organon (OGN) Interim CEO Joseph Morrissey Exercises RSUs, Withholds Shares

What Happened

  • Joseph T. Morrissey Jr., Interim CEO of Organon & Co. (OGN), had 9,752 restricted stock units (RSUs) convert into shares on March 29, 2026 (reported on Form 4 filed 2026-03-31). To satisfy tax withholding, 2,779 of those shares were withheld/sold at $5.84 per share, generating about $16,229. Net shares delivered to Morrissey after withholding were 6,973 (9,752 - 2,779).
  • Transaction codes: M = exercise/conversion of a derivative (RSU conversion into shares, no cash exercise price), F = shares withheld/sold to cover tax liability.

Key Details

  • Transaction date: 2026-03-29; Filing date: 2026-03-31 (appears within the normal reporting window).
  • Prices and values: Tax withholding reported at $5.84 per share (closing price on 2026-03-27) for 2,779 shares = $16,229.
  • Shares acquired via conversion: 9,752 RSUs → 9,752 shares (gross); 2,779 shares withheld; net received = 6,973 shares.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes: F1 confirms the $5.84 per-share figure is the closing market price on 2026-03-27; F2 notes each RSU equals one share; F3 notes the RSUs vest in three equal installments (3/29/2025, 3/29/2026, 3/29/2027).

Context

  • This was not an open-market purchase; it was the scheduled vesting/conversion of RSUs. The withholding of shares to cover taxes (code F) is a routine administrative step and not necessarily a market sentiment signal.
  • For retail investors, the key takeaways are the number of shares added to the insider’s holdings (net 6,973) and that the reported disposal (2,779 shares) was solely for tax withholding rather than an intentional sale for liquidity.

Insider Transaction Report

Form 4
Period: 2026-03-29
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-29+9,752108,322.923 total
  • Tax Payment

    Common Stock

    [F1]
    2026-03-29$5.84/sh2,779$16,229105,543.923 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-03-299,7529,752 total
    Common Stock (9,752 underlying)
Footnotes (3)
  • [F1]This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
  • [F2]Each RSU represents a contingent right to receive one share of Organon common stock.
  • [F3]These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Joseph T. Morrissey, Jr.|2026-03-31

Documents

1 file
  • 4
    wk-form4_1774987546.xmlPrimary

    FORM 4